NCT00940225 2024-04-25Study of Cabozantinib (XL184) in Adults With Advanced MalignanciesExelixisPhase 2 Completed730 enrolled 25 charts
NCT01709435 2023-12-22Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed41 enrolled 20 charts